However, inhibition of EZH2 expression or its methyltransferase activity promoted chemosensitivity through the induction of SLFN11 expression in small cell lung cancer (Gardner et al., 2017), which is contrary to our results in CRC. The gene discussed is EZH2; the disease is colorectal carcinoma.